Evidence map›Paper›PMID 27384551›Full record

ArticleMolecules (Basel, Switzerland)2016

Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells.

Marcilia P Costa, Anderson C S Feitosa, Fátima C E Oliveira, Bruno C Cavalcanti, Eufrânio N da Silva, Gleiston G Dias, Francisco A M Sales, Bruno L Sousa, Ito L Barroso-Neto, Cláudia Pessoa and 5 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marcilia P CostaDepartment of Physiology and Pharmacology, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil. marciliapc@ufpi.edu.br.
Anderson C S FeitosaDepartment of Physiology and Pharmacology, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil. acs_feitosa@yahoo.com.br.
Fátima C E OliveiraDepartment of Physiology and Pharmacology, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil. cassiadefatima3006@gmail.com.
Bruno C CavalcantiDepartment of Physiology and Pharmacology, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil. nunim_br@yahoo.com.br.
Eufrânio N da SilvaDepartment of Chemistry, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil. eufranio@ufmg.br.
Gleiston G DiasDepartment of Chemistry, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil. diasgg@yahoo.com.br.
Francisco A M SalesDepartment of Physics, Federal University of Ceará, 60455-760 Fortaleza, CE, Brazil. adilson.sales@gmail.com.
Bruno L SousaDepartment of Physics, Federal University of Ceará, 60455-760 Fortaleza, CE, Brazil. brunolopesdesousa@gmail.com.
Ito L Barroso-NetoDepartment of Analytical Chemistry and Physical Chemistry, Federal University of Ceará, 60455-760 Fortaleza, CE, Brazil. itoliberato@gmail.com.
Cláudia PessoaDepartment of Physiology and Pharmacology, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil. cpessoa@ufc.br.
Ewerton W S CaetanoDepartment of Secondary School and Teachers College, Federal Institute of Ceará, 60040-531 Fortaleza, CE, Brazil. ewcaetano@gmail.com.
Stefano Di FioreFraunhofer Institute for Molecular Biology and Applied Ecology IME, 52074, Aachen, Germany. stefano.difiore@ime.fraunhofer.de.
Rainer FischerFraunhofer Institute for Molecular Biology and Applied Ecology IME, 52074, Aachen, Germany. rainer.fischer@ime.fraunhofer.de.
Luiz O LadeiraDepartment of Physics, Federal University of Minas Gerais, 31340-550 Belo Horizonte, MG, Brazil. loladeira@gmail.com.
Valder N FreireDepartment of Analytical Chemistry and Physical Chemistry, Federal University of Ceará, 60455-760 Fortaleza, CE, Brazil. vnffreire@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting drug-loaded system against metastatic prostate cancer cells. The microcapsules presented appropriate morphological features and the presence of drug molecules in the microcapsules was confirmed by different methods. Spherical microcapsules with a size range of 1.03 ± 0.46 μm were produced with an encapsulation efficiency of approximately 19%. Classical molecular dynamics calculations provided an estimate of the typical adsorption energies of NβL on PLGA. Finally, the cytotoxic activity of NβL against PC3M human prostate cancer cells was demonstrated to be significantly enhanced when delivered by PLGA microcapsules in comparison with the free drug.

Indexed as

CapsulesDelayed-Action PreparationsDrug CarriersLactic AcidPolyglycolic AcidAntineoplastic AgentsBenzofuransCell Line, TumorCell SurvivalDrug Delivery SystemsHumansInhibitory Concentration 50MaleModels, MolecularMolecular ConformationMolecular StructureAntineoplastic AgentsBenzofuransCapsulesDelayed-Action PreparationsDrug CarriersLactic AcidNaphthoquinonesnor-beta-lapachonePolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymercancerlapacholnaphthoquinonenor-β-lapachonePLGA microcapsulesprostate

Identifiers

PMID27384551
PMCPMC6273703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.